Skip to content

Intravenous low dose ketamine compound low dose butorphanol during repeat caesarean section: A prospective randomized controlled trial

Intravenous low dose ketamine compound low dose butorphanol during repeat caesarean section: A prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17013412
Enrollment
Unknown
Registered
2017-11-16
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean delivery

Interventions

Group KB:low dose ketamine + low dose butorphanol

Sponsors

Liaocheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA I and II, aged 18 to 40 years, elective repeat caesarean section, = 37 weeks of gestation;Inclusion criteria: ASA I and II, aged 18 to 40 years, elective repeat caesarean section, = 37 weeks of gestation

Exclusion criteria

Exclusion criteria: BMI =40kg/m2, significant co-existing disease, substance abuse, other psychiatric drug use, Neurological or psychiatric diseases, contraindications for spinal anaesthesia, allergy to study medicationsa history of chronic pain;Exclusion criteria: BMI =40kg/m2, significant co-existing disease, substance abuse, other psychiatric drug use, Neurological or psychiatric diseases, contraindications for spinal anaesthesia, allergy to study medicationsa history of chronic pain

Design outcomes

Primary

MeasureTime frame
Depression anxiety score;visceral traction response;nausea and vomiting;shivering;pruritus;Perioperative analgesic drug consumption;Maternity satisfaction;Postoperative pain score;;Depression anxiety score;visceral traction response;nausea and vomiting;shivering;pruritus;Perioperative analgesic drug consumption;Maternity satisfaction;Postoperative pain score;

Secondary

MeasureTime frame
Vital signs;Ramsay sedation score;intestinal gas exhaust;Obstetrician satisfaction;Adverse drug reaction;uroschesis;;Vital signs;Ramsay sedation score;intestinal gas exhaust;Obstetrician satisfaction;Adverse drug reaction;uroschesis;

Countries

China

Contacts

Public ContactZhang Ping;Zhang Ping ;

Liaocheng People's Hospital;Liaocheng People's Hospital

hiaomi@163.com;hiaomi@163.com+86 15020607190;+86 15020607190

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026